Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Ticagrelor Plus Warfarin vs Triple Therapy in AF Patients Undergoing PCI
NCT02206815Phase 4Completed
- Start
- Sep 2014
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ticagrelor in Atrial fibrillation (AFib), coronary artery disease (CAD). Started Sep 2014; status: completed.
02
Drugs
ticagrelor
03
Conditions
Atrial fibrillation (AFib)coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02206815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02206815.